17 Education & Technology Group Inc.
Rank #452DeclineYQ · Nasdaq · Consumer Defensive
17 Education & Technology Group Inc. (YQ) — Rank #452 by gross profitability (GP/assets 0.09) · ROE -53.9% · Piotroski F-Score 4 / 9.
As-of 2026-09-15 · CIK 0001821468 · all metrics point-in-time as of the filing date.
About
17 Education & Technology Group Inc., an education technology company, provides education and education technology services in the People's Republic of China.
Show moreShow less
It provides teaching and learning SaaS products, such as classroom solutions, question banks, homework assignments, self-directed learning, and multi-role reporting, etc. for regional educational authorities and schools. The company also provides other educational products and services, including membership-based premium educational content subscriptions to its selected educational contents, light courses, Chinese reading, math oral arithmetic, reading machines, study plans, and associated services. 17 Education & Technology Group Inc.
was incorporated in 2012 and is headquartered in Beijing, the People's Republic of China.
- Industry
- Education & Training Services
- Sector
- Consumer Defensive
- State
- F4
- Filer Category
- Non-accelerated filer
- Fiscal Year End
- December 31
- Website
- ir.17zuoye.com
Price History
Company Snapshot
P/E, P/B, and dividend yield matter most — book value provides a floor.
Market Cap
$32.84M
P/E (annual)
—
P/S (annual)
0.3
P/B
0.1
P/OCF (annual)
0.9
Shareholder Yield
-24.7%
Employees
1,017
Industry
Education & Training Services
Exchange
Nasdaq
Signal Flags
Quality Profile
Profitability
1/1 passSafety
1/1 passCash Flow
3/3 passGrowth
0/2 passTerry Smith quality gate
Passes 0/5 Terry Smith thresholds2 of 5 thresholds not computable from filed data.
What Growth Is Priced In
Implied revenue growth (10Y)
21.7%
The annual FCF growth rate today's price requires over a 10-year horizon (discount rate 10%, terminal growth 2.5%).
Dilution drag: 24.7% — per-share value needs a total required return of 46.4% once share-count change is priced in.
vs. own 6-year median revenue growth: -16.6%
Cost-of-equity sensitivity (implied growth at different discount rates)
r = 8%
16.6%
r = 10% (base)
21.7%
r = 12%
26.1%
Net debt / market cap: -24.0%
Note: current FCF margin is 1.9σ above its historical mean — implied growth may understate valuation risk if the margin reverts.
Valuation History
Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.
P / S
Price / revenue per share
P / B
Price / book value per share
P / GP
Price / gross profit per share
Earnings bubble check
Current margins may be above sustainable levels — a P/E based on peak earnings can overstate cheapness.
Asset value and restructuring potential (balance-sheet strength) are the primary reads at this stage.
Profitability
Gross profitability (GP / assets)
0.09
Primary signal (Novy-Marx).
8th of 8 SIC 8200 peers
Return on equity
-53.9%
Gross margin
47.8%
6th of 8 SIC 8200 peers
Revenue growth (YoY)
-44.0%
Gross margin improving
Margin trend vs prior year.
Operating Leverage
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Revenue vs COGS | ||||
| Revenue vs OpEx | ||||
| Op. Income vs Revenue |
Growth
Revenue CAGR (3Y)
-41.6%
Revenue CAGR (5Y)
-39.4%
Earnings CAGR (3Y)
—
FCF CAGR (3Y)
—
Anti-fragile safety
Balance-sheet safety
Composite anti-fragile check.
Debt / equity
1.06
6th of 8 SIC 8200 peers (best = lowest)
Current ratio
1.87×
4th of 8 SIC 8200 peers
Quick ratio
1.53×
Net cash
$406.92M
Cash & equivalents minus total debt.
Cash-flow health
Free cash flow
$30.46M
Operating cash flow minus capex.
Positive free cash flow
FCF / net income
1.20
Cash-backing of earnings.
FCF/NI divergence
Unfavorable divergence (yellow flag).
Accruals healthy
Cash-backed earnings.
SBC / revenue
29.1%
Stock-based comp intensity.
Piotroski F-Score
F-Score
4 / 9
Fundamental-strength score (0-9).
Lifecycle Phase History
Lynch sell alert: Turnaround stalled
Classified decline for 2 consecutive fiscal years (2024-12-31, 2025-12-31) with no recovery to a healthier phase -- Lynch's turnaround rule: if it hasn't turned around by now, assume it isn't going to.